Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
European market rebound led by pharma gains (EUR:USD:)
Follow us on Google for the latest stock news London (UKX) +0.12% at 9,877. Germany (DAX:IND) +0.10% at 24,307. Germany's import prices fell 1.9% Y/Y in November. France (CAC:IND) -0.08% at 8,114. In other parts of Europe, Spain's GDP expands 2.8%…
Hawley, Tuberville Stand Against Big Pharma's End-Run Around Rural Health Care
Democrats will spend 2026 blaming Medicaid reforms and expired Obamacare subsidies for healthcare problems in red states. They won't mention the bigger threat: pharmaceutical companies rewriting the rules of a federal drug discount program that's…
Ajanta Pharma signs pact with Biocon for Semaglutide
Ajanta Pharma has entered into an in-licensing agreement with Biocon for Semaglutide. Under the agreement, Biocon will supply Semaglutide to Ajanta for exclusive marketing in 23 countries and semi-exclusive marketing in 3 countries across Africa…
Regencell Bioscience is the top performing pharma stock YTD (RGC:NASDAQ)
Follow us on Google for the latest stock news The S&P healthcare index (XLV) saw moderate gains in 2025, reaching a YTD increase of 12.2% by mid-December, though it fell short of its May highs. The sector is the sixth-highest performing sector…
Ajanta Pharma to sell Biocon's semaglutide in 26 markets
Ajanta Pharma has entered into an in-licensing agreement with Biocon for semaglutide, the active ingredient in weight-loss and diabetes drugs Wegovy and Ozempic. Biocon will supply semaglutide to Ajanta for exclusive marketing in 23 countries and…
LSL PHARMA GROUP CLOSES $10M OF UPSIZED $12M BROKERED OFFERING AND ENTERS INTO DEFINITIVE AGREEMENT FOR THE ACQUISITION OF JUNO OTC
BOUCHERVILLE, QC, Dec. 23, 2025 /CNW/ - LSL PHARMA GROUP INC. (TSXV: LSL) (The 'Corporation' or ' LSL Pharma'), a Canadian integrated pharmaceutical company, is pleased to announce that it has completed the closing of an initial tranche of its…
Zealand Pharma A/S (OTCMKTS:ZLDPF) Shares Gap Up - Time to Buy?
Zealand Pharma A/S (OTCMKTS:ZLDPF - Get Free Report) shares gapped up prior to trading on Tuesday. The stock had previously closed at $72.08, but opened at $75.24. Zealand Pharma A/S shares last traded at $75.24, with a volume of 1,000 shares. A…
Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Down - What's Next?
Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report) gapped down before the market opened on Tuesday. The stock had previously closed at $29.31, but opened at $27.40. Ascentage Pharma Group International shares…
Innate Pharma (NASDAQ:IPHA) Shares Up 2.3% - Should You Buy?
Innate Pharma S.A. Sponsored ADR (NASDAQ:IPHA - Get Free Report) shares rose 2.3% during trading on Monday. The stock traded as high as $1.81 and last traded at $1.79. Approximately 36,311 shares were traded during mid-day trading, an increase of…
Zealand Pharma A/S (OTCMKTS:ZLDPF) Receives Consensus Rating of 'Strong Buy' from Analysts
Shares of Zealand Pharma A/S (OTCMKTS:ZLDPF - Get Free Report) have received an average rating of 'Strong Buy' from the eight ratings firms that are currently covering the stock, MarketBeat.com reports. Two investment analysts have rated the stock…
Sensex slips 43 pts; IT shares fall on profit-taking
Benchmark stock index BSE Sensex slipped by 43 points in a volatile trade on Tuesday following profit-taking in IT and pharma shares and mixed global cues. Snapping the two-day gaining streak, the 30-share BSE Sensex dipped 42.64 points or 0.05 per…
Lilly-backed radiopharma startup Aktis seeks U.S. IPO (AKTS:Pending)
Follow us on Google for the latest stock news Aktis Oncology (AKTS), a radiopharmaceutical drug developer backed by pharma giants such as Eli Lilly (LLY), has filed its preliminary regulatory filings with the Securities and Exchange Commission for…
FHLC: Why Patience Matters More Than Precision (NYSEARCA:FHLC)
Fidelity MSCI Health Care Index ETF offers long-term growth potential, leveraging demographic tailwinds and biotech innovation, but requires patience through cycles. FHLC's market-cap weighting enables dynamic exposure, reducing biotech risk in…
The MAHA base is in danger of fracturing as its agenda flails
Defenders of the slow pace of progress at Health and Human Services — especially on vaccines — argue that Health Secretary Robert Kennedy is not a king. He works for President Trump and has certain limitations. He is doing the best he…
India's Strong Growth Cushions Impact Of US Tariffs, FTAs Driving Market Diversification: IIFT VC
India's strong economic growth has helped cushion the impact of higher U.S. tariffs on key export sectors, allowing the country to remain resilient while accelerating free trade agreements to diversify markets, boost services exports and attract…
Receive a Daily briefing on Pharma Industry News
Get Started